rs374030184
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001323289.2(CDKL5):c.464-9A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000747 in 1,164,119 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.000069 ( 0 hom. 21 hem. )
Consequence
CDKL5
NM_001323289.2 splice_polypyrimidine_tract, intron
NM_001323289.2 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.000006842
2
Clinical Significance
Conservation
PhyloP100: -0.911
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-18584254-A-G is Benign according to our data. Variant chrX-18584254-A-G is described in ClinVar as [Benign]. Clinvar id is 533399.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-18584254-A-G is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.464-9A>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000623535.2 | NP_001310218.1 | |||
CDKL5 | NM_001037343.2 | c.464-9A>G | splice_polypyrimidine_tract_variant, intron_variant | NP_001032420.1 | ||||
CDKL5 | NM_003159.3 | c.464-9A>G | splice_polypyrimidine_tract_variant, intron_variant | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.464-9A>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001323289.2 | ENSP00000485244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 14AN: 111945Hom.: 0 Cov.: 23 AF XY: 0.000147 AC XY: 5AN XY: 34123
GnomAD3 genomes
AF:
AC:
14
AN:
111945
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34123
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000983 AC: 18AN: 183096Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67688
GnomAD3 exomes
AF:
AC:
18
AN:
183096
Hom.:
AF XY:
AC XY:
8
AN XY:
67688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000694 AC: 73AN: 1052174Hom.: 0 Cov.: 25 AF XY: 0.0000641 AC XY: 21AN XY: 327536
GnomAD4 exome
AF:
AC:
73
AN:
1052174
Hom.:
Cov.:
25
AF XY:
AC XY:
21
AN XY:
327536
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 14AN: 111945Hom.: 0 Cov.: 23 AF XY: 0.000147 AC XY: 5AN XY: 34123
GnomAD4 genome
AF:
AC:
14
AN:
111945
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34123
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at